A new-generation stable inducible packaging cell line for lentiviral vectors

D. Farson, R. Witt, R. McGuinness, T. Dull, M. Kelly, J. Song, R. Radeke, A. Bukovsky, A. Consiglio, L. Naldini

Research output: Contribution to journalArticle

108 Citations (Scopus)

Abstract

We have successfully generated and characterized a stable packaging cell line for HIV-1-based vectors. To allow safe production of vector, a minimal packaging construct carrying only the coding sequences of the HIV-1 gag-pol, tat, and rev genes was stably introduced into 293G cells under the control of a Teto minimal promoter. 293G cells express the chimeric TetR/VP16 trans-activator and contain a tetracycline-regulated vesicular stomatitis virus protein G (VSV-G) envelope gene. When the cells were grown in the presence of tetracycline the expression of both HIV-1-derived and VSV-derived packaging functions was suppressed. On induction, approximately 50 ng/ml/24 hr of Gag p24 equivalent of vector was obtained. After introduction of the transfer vector by serial infection, vector could be collected for several days with a transduction efficiency similar or superior to that of vector produced by transient transfection both for dividing and growth-arrested cells. The vector could be effectively concentrated to titers reaching 109 transducing units/ml and allowed for efficient delivery and stable expression of a GFP transgene in the mouse brain. The packaging cell line and all vector producer clones described here were shown to be free from replication-competent recombinants, and from recombinants between packaging and vector constructs that transfer the viral gag-pol genes. The packaging cell line and the assays developed will advance lentiviral vectors toward the stringent requirements of clinical applications.

Original languageEnglish
Pages (from-to)981-997
Number of pages17
JournalHuman Gene Therapy
Volume12
Issue number8
DOIs
Publication statusPublished - 2001

Fingerprint

Product Packaging
Cell Line
pol Genes
gag Genes
HIV-1
Tetracycline
rev Genes
tat Genes
Trans-Activators
Viral Genes
Transgenes
Transfection
Clone Cells
Brain
Growth
Infection
Genes

ASJC Scopus subject areas

  • Genetics

Cite this

A new-generation stable inducible packaging cell line for lentiviral vectors. / Farson, D.; Witt, R.; McGuinness, R.; Dull, T.; Kelly, M.; Song, J.; Radeke, R.; Bukovsky, A.; Consiglio, A.; Naldini, L.

In: Human Gene Therapy, Vol. 12, No. 8, 2001, p. 981-997.

Research output: Contribution to journalArticle

Farson, D, Witt, R, McGuinness, R, Dull, T, Kelly, M, Song, J, Radeke, R, Bukovsky, A, Consiglio, A & Naldini, L 2001, 'A new-generation stable inducible packaging cell line for lentiviral vectors', Human Gene Therapy, vol. 12, no. 8, pp. 981-997. https://doi.org/10.1089/104303401750195935
Farson, D. ; Witt, R. ; McGuinness, R. ; Dull, T. ; Kelly, M. ; Song, J. ; Radeke, R. ; Bukovsky, A. ; Consiglio, A. ; Naldini, L. / A new-generation stable inducible packaging cell line for lentiviral vectors. In: Human Gene Therapy. 2001 ; Vol. 12, No. 8. pp. 981-997.
@article{0a60e49d5c204b5db1f7f17f11616947,
title = "A new-generation stable inducible packaging cell line for lentiviral vectors",
abstract = "We have successfully generated and characterized a stable packaging cell line for HIV-1-based vectors. To allow safe production of vector, a minimal packaging construct carrying only the coding sequences of the HIV-1 gag-pol, tat, and rev genes was stably introduced into 293G cells under the control of a Teto minimal promoter. 293G cells express the chimeric TetR/VP16 trans-activator and contain a tetracycline-regulated vesicular stomatitis virus protein G (VSV-G) envelope gene. When the cells were grown in the presence of tetracycline the expression of both HIV-1-derived and VSV-derived packaging functions was suppressed. On induction, approximately 50 ng/ml/24 hr of Gag p24 equivalent of vector was obtained. After introduction of the transfer vector by serial infection, vector could be collected for several days with a transduction efficiency similar or superior to that of vector produced by transient transfection both for dividing and growth-arrested cells. The vector could be effectively concentrated to titers reaching 109 transducing units/ml and allowed for efficient delivery and stable expression of a GFP transgene in the mouse brain. The packaging cell line and all vector producer clones described here were shown to be free from replication-competent recombinants, and from recombinants between packaging and vector constructs that transfer the viral gag-pol genes. The packaging cell line and the assays developed will advance lentiviral vectors toward the stringent requirements of clinical applications.",
author = "D. Farson and R. Witt and R. McGuinness and T. Dull and M. Kelly and J. Song and R. Radeke and A. Bukovsky and A. Consiglio and L. Naldini",
year = "2001",
doi = "10.1089/104303401750195935",
language = "English",
volume = "12",
pages = "981--997",
journal = "Human Gene Therapy",
issn = "1043-0342",
publisher = "Mary Ann Liebert Inc.",
number = "8",

}

TY - JOUR

T1 - A new-generation stable inducible packaging cell line for lentiviral vectors

AU - Farson, D.

AU - Witt, R.

AU - McGuinness, R.

AU - Dull, T.

AU - Kelly, M.

AU - Song, J.

AU - Radeke, R.

AU - Bukovsky, A.

AU - Consiglio, A.

AU - Naldini, L.

PY - 2001

Y1 - 2001

N2 - We have successfully generated and characterized a stable packaging cell line for HIV-1-based vectors. To allow safe production of vector, a minimal packaging construct carrying only the coding sequences of the HIV-1 gag-pol, tat, and rev genes was stably introduced into 293G cells under the control of a Teto minimal promoter. 293G cells express the chimeric TetR/VP16 trans-activator and contain a tetracycline-regulated vesicular stomatitis virus protein G (VSV-G) envelope gene. When the cells were grown in the presence of tetracycline the expression of both HIV-1-derived and VSV-derived packaging functions was suppressed. On induction, approximately 50 ng/ml/24 hr of Gag p24 equivalent of vector was obtained. After introduction of the transfer vector by serial infection, vector could be collected for several days with a transduction efficiency similar or superior to that of vector produced by transient transfection both for dividing and growth-arrested cells. The vector could be effectively concentrated to titers reaching 109 transducing units/ml and allowed for efficient delivery and stable expression of a GFP transgene in the mouse brain. The packaging cell line and all vector producer clones described here were shown to be free from replication-competent recombinants, and from recombinants between packaging and vector constructs that transfer the viral gag-pol genes. The packaging cell line and the assays developed will advance lentiviral vectors toward the stringent requirements of clinical applications.

AB - We have successfully generated and characterized a stable packaging cell line for HIV-1-based vectors. To allow safe production of vector, a minimal packaging construct carrying only the coding sequences of the HIV-1 gag-pol, tat, and rev genes was stably introduced into 293G cells under the control of a Teto minimal promoter. 293G cells express the chimeric TetR/VP16 trans-activator and contain a tetracycline-regulated vesicular stomatitis virus protein G (VSV-G) envelope gene. When the cells were grown in the presence of tetracycline the expression of both HIV-1-derived and VSV-derived packaging functions was suppressed. On induction, approximately 50 ng/ml/24 hr of Gag p24 equivalent of vector was obtained. After introduction of the transfer vector by serial infection, vector could be collected for several days with a transduction efficiency similar or superior to that of vector produced by transient transfection both for dividing and growth-arrested cells. The vector could be effectively concentrated to titers reaching 109 transducing units/ml and allowed for efficient delivery and stable expression of a GFP transgene in the mouse brain. The packaging cell line and all vector producer clones described here were shown to be free from replication-competent recombinants, and from recombinants between packaging and vector constructs that transfer the viral gag-pol genes. The packaging cell line and the assays developed will advance lentiviral vectors toward the stringent requirements of clinical applications.

UR - http://www.scopus.com/inward/record.url?scp=0034914353&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034914353&partnerID=8YFLogxK

U2 - 10.1089/104303401750195935

DO - 10.1089/104303401750195935

M3 - Article

VL - 12

SP - 981

EP - 997

JO - Human Gene Therapy

JF - Human Gene Therapy

SN - 1043-0342

IS - 8

ER -